We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+2.52%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$7.16B
AUM Growth
+$666M
(+10%)
Cap. Flow
+$831M
Cap. Flow
% of AUM
11.61%
Top 10 Holdings %
Top 10 Hldgs %
17.05%
Holding
983
New
189
Increased
207
Reduced
145
Closed
240
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$146M |
| 2 |
Gilead Sciences
GILD
|
+$116M |
| 3 |
Amazon
AMZN
|
+$86.4M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$84.7M |
| 5 |
Analog Devices
ADI
|
+$80M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$73.2M |
| 2 |
Palo Alto Networks
PANW
|
+$59.8M |
| 3 |
Alkermes
ALKS
|
+$55.3M |
| 4 |
Accenture
ACN
|
+$53.8M |
| 5 |
Johnson & Johnson
JNJ
|
+$53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.05% |
| 2 | Technology | 29.2% |
| 3 | Financials | 8.76% |
| 4 | Industrials | 7.7% |
| 5 | Communication Services | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Automatic Data Processing
ADP
$106B
| $20M | 0.28% |
88,257
-47,763
| -35% | -$11.3M |
|
102
Silicon Motion
SIMO
$9.05B
| $19.9M | 0.28% |
305,600
+1,600
| +0.5% | +$125K |
|
103
Biogen
BIIB
$30.6B
| $19.7M | 0.28% |
73,954
+36,542
| +98% | +$7.76M |
|
104
Intellia Therapeutics
NTLA
$1.56B
| $19.4M | 0.27% |
347,271
+288,610
| +492% | +$17.9M |
|
105
PayPal
PYPL
$49.7B
| $19.4M | 0.27% |
225,263
+142,993
| +174% | +$12.7M |
|
106
Cadence Design Systems
CDNS
$93.9B
| $19.4M | 0.27% |
118,484
+47,124
| +66% | +$8.1M |
|
107
Microchip Technology
MCHP
$43.6B
| $19.4M | 0.27% |
317,213
-657,725
| -67% | -$43.2M |
|
|
CVII
108
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
| $19.3M | 0.27% |
1,959,799
+1,459,799
| +292% | +$14.3M |
|
109
Bristol-Myers Squibb
BMY
$134B
| $19M | 0.27% |
267,900
-582,280
| -68% | -$42.2M |
|
110
Syndax Pharmaceuticals
SNDX
$1.73B
| $19M | 0.27% |
+789,273
| New | +$17.7M |
|
111
Sensata Technologies
ST
$7.03B
| $18.7M | 0.26% |
+501,727
| New | +$21M |
|
112
Johnson Controls International
JCI
$93.3B
| $18.7M | 0.26% |
379,832
-241,507
| -39% | -$12.8M |
|
113
Edgewell Personal Care
EPC
$1.3B
| $18.6M | 0.26% |
496,240
+46,879
| +10% | +$1.83M |
|
114
Ulta Beauty
ULTA
$23.4B
| $18.4M | 0.26% |
45,911
+4,956
| +12% | +$2M |
|
|
SGFY
115
DELISTED
Signify Health, Inc.
SGFY
| $18.4M | 0.26% |
630,300
+278,514
| +79% | +$6.42M |
|
116
Lumentum
LITE
$66.6B
| $18.1M | 0.25% |
264,279
+113,982
| +76% | +$9.44M |
|
|
ONEM
117
DELISTED
1Life Healthcare
ONEM
| $18M | 0.25% |
+1,050,500
| New | +$16.5M |
|
118
Ionis Pharmaceuticals
IONS
$9.15B
| $18M | 0.25% |
406,483
+276,575
| +213% | +$11.7M |
|
119
News Corp Class A
NWSA
$15.3B
| $17.9M | 0.25% |
1,184,480
-41,231
| -3% | -$691K |
|
120
Trade Desk
TTD
$8.9B
| $17.6M | 0.25% |
294,930
+286,736
| +3,499% | +$16.3M |
|
121
BioMarin Pharmaceuticals
BMRN
$11.7B
| $17.4M | 0.24% |
204,693
-198,476
| -49% | -$17.7M |
|
122
Universal Health Services
UHS
$9.99B
| $17.1M | 0.24% |
+194,075
| New | +$20.1M |
|
123
Omnicom Group
OMC
$21.9B
| $17M | 0.24% |
268,756
-146,244
| -35% | -$9.92M |
|
124
Power Integrations
POWI
$3.53B
| $16.8M | 0.24% |
+261,831
| New | +$19.6M |
|
125
Tower Semiconductor
TSEM
$27.3B
| $16.8M | 0.23% |
382,000
+2,000
| +0.5% | +$92.1K |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Woodline Partners held 983 positions worth $7.16B, up 10% from $6.49B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Woodline Partners deployed $831M of net new capital in Q3 2022, opening 189 new positions and adding to 207 existing holdings. Its largest new stake was Amazon: 683,398 shares worth $77.2M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $73.2M trimmed.
- Woodline Partners's largest Q3 2022 buy was Amazon: 683,398 shares worth $77.2M.
- Woodline Partners added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2022, an estimated $146M increase.
- Woodline Partners's biggest Q3 2022 reduction was Eli Lilly, cutting an estimated $73.2M.
- Woodline Partners fully exited Palo Alto Networks in Q3 2022, selling an estimated $59.8M.
- Woodline Partners's ten largest holdings make up 17% of its $7.16B portfolio in Q3 2022.
- Woodline Partners opened 189 new positions and closed 240 in Q3 2022.
- Woodline Partners's portfolio value rose 10% quarter-over-quarter to $7.16B.
Based on Woodline Partners's 13F filing for Q3 2022, filed 14 Nov 2022.